NCT02144077 2022-11-03
Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy
Biofrontera Bioscience GmbH
Phase 3 Completed
Biofrontera Bioscience GmbH
Joint Authority for Päijät-Häme Social and Health Care